ketoprofen has been researched along with Fatty Liver, Nonalcoholic in 2 studies
Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have developed a co-assembled nanosystem based on fenofibrate and ketoprofen by tactfully utilizing their simultaneous benzophenone interaction, which greatly enhances the bioavailability of fenofibrate and plays a role in the dual-targeted treatment of NAFLD by reducing hepatic lipid accumulation and inflammatory responses." | 5.56 | Simultaneous co-assembly of fenofibrate and ketoprofen peptide for the dual-targeted treatment of nonalcoholic fatty liver disease (NAFLD). ( Fan, G; Liu, J; Ma, C; Ren, C; Shang, Y; Wang, Z; Yang, C; Yang, L; Zhang, J, 2020) |
| "We have developed a co-assembled nanosystem based on fenofibrate and ketoprofen by tactfully utilizing their simultaneous benzophenone interaction, which greatly enhances the bioavailability of fenofibrate and plays a role in the dual-targeted treatment of NAFLD by reducing hepatic lipid accumulation and inflammatory responses." | 1.56 | Simultaneous co-assembly of fenofibrate and ketoprofen peptide for the dual-targeted treatment of nonalcoholic fatty liver disease (NAFLD). ( Fan, G; Liu, J; Ma, C; Ren, C; Shang, Y; Wang, Z; Yang, C; Yang, L; Zhang, J, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 1 |
| Ma, C | 1 |
| Shang, Y | 1 |
| Yang, L | 1 |
| Zhang, J | 1 |
| Yang, C | 1 |
| Ren, C | 1 |
| Liu, J | 2 |
| Fan, G | 1 |
| Famularo, G | 1 |
| Gasbarrone, L | 1 |
| Minisola, G | 1 |
2 other studies available for ketoprofen and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Simultaneous co-assembly of fenofibrate and ketoprofen peptide for the dual-targeted treatment of nonalcoholic fatty liver disease (NAFLD).
Topics: Fenofibrate; Humans; Inflammation; Ketoprofen; Lipid Metabolism; Molecular Structure; Non-alcoholic | 2020 |
Probable ketoprofen-associated nonalcoholic fatty liver disease and steatohepatitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Fatty Liver; Female; Humans; Ketoprofen; Middle Aged; Non-a | 2011 |